Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001527204-25-000005
Filing Date
2025-12-29
Accepted
2025-12-29 16:10:05
Documents
1
Period of Report
2025-12-29

Document Format Files

Seq Description Document Type Size
1 form4-12292025_041201.html 4  
1 form4-12292025_041201.xml 4 3119
  Complete submission text file 0001527204-25-000005.txt   4759
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Jorkasky Diane (Reporting) CIK: 0001527204 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 251609257